The Minister for Health and Social Services has endorsed AWMSG's recommendation to support the use of anagrelide within NHS Wales in accordance with its licensed indications and subject to the formation of a uniform pathway for the management of patients with essential thrombocythaemia throughout Wales. AWMSG would like haematologists as a professional group to monitor patients and address concerns with regard to long-term safety issues.